Previous close | 31.40 |
Open | 31.00 |
Bid | 30.00 x N/A |
Ask | 31.40 x N/A |
Day's range | 31.00 - 31.00 |
52-week range | 16.40 - 54.50 |
Volume | |
Avg. volume | 0 |
Market cap | 2.378B |
Beta (5Y monthly) | 0.67 |
PE ratio (TTM) | N/A |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | N/A |
PTC Therapeutics shows improving price performance, earning an upgrade to its IBD Relative Strength Rating
PTC Therapeutics, Inc. (NASDAQ:PTCT) Q1 2024 Earnings Call Transcript April 25, 2024 PTC Therapeutics, Inc. beats earnings expectations. Reported EPS is $-1.2, expectations were $-1.31. PTC Therapeutics, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Good day and thank […]
PTC Therapeutics, Inc. ( NASDAQ:PTCT ) shareholders will have a reason to smile today, with the analysts making...